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Aneuploidy is a major source of gene dosage imbalance due to copy number alterations
(CNA), and viable human trisomies are model disorders of altered gene expression. We
study gene and allele-specific expression (ASE) of 9668 single-cell fibroblasts from trisomy
21 (T21) discordant twins and from mosaic T21, T18, T13 and T8. We examine 928 single cells
with deep scRNAseq. Expected and observed overexpression of trisomic genes in trisomic vs.
diploid bulk RNAseq is not detectable in trisomic vs. diploid single cells. Instead, for trisomic
genes with low-to-average expression, their altered gene dosage is mainly due to the higher
fraction of trisomic cells simultaneously expressing these genes, in agreement with a sto-
chastic 2-state burst-like model of transcription. These results, confirmed in a further analysis
of 8740 single fibroblasts with shallow scRNAseq, suggest that the specific transcriptional
profile of each gene contributes to the phenotypic variability of trisomies. We propose an
improved model to understand the effects of CNA and, generally, of gene regulation on gene
dosage imbalance.
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The biochemical processes underlying complex cellularfunctions rely on a precise and timely dosage of theirconstitutive elements and, in particular, of protein stoi-
chiometry1. Protein production is inherently connected with gene
expression level, which, in turn, is regulated by several factors of
genetic and epigenetic nature2. Perturbation of this equilibrium
may induce severe cellular and organismal phenotypes. Genomic
copy number alterations (CNA) such as duplications and dele-
tions, result in gene expression imbalance3 and is associated with
reproducible phenotypes as it is the case in aneuploidies. How-
ever the respective functional mechanisms are not well
understood.
Aneuploidy is a well-known source of gene dosage imbalance
through CNA. In particular trisomies are considered to be dis-
orders of altered gene expression of the majority of genes on the
supernumerary chromosomes (gene dosage sensitive genes)4–8.
Trisomy 21 (T21—Down syndrome) is the most common human
aneuploidy compatible with postnatal survival, and has been
extensively used as a model to study trisomies9. Other common
trisomies include Trisomy 18 (T18—Edwards’s syndrome) and
Trisomy 13 (T13—Patau syndrome)10–13. Phenotypes observed
in trisomies have been attributed from bulk RNA-seq studies to
the gene dosage imbalance, ~1.5 fold higher for the trisomic genes
as compared to their diploid counterparts6,14–16. However the
causative links between altered gene expression and phenotypes
in aneuploidies are not known. To understand the molecular
basis of trisomy phenotypes, we explored gene expression profiles
in single trisomic cells. Hitherto, single-cell RNA-seq (scRNAseq)
studies have revealed pervasive genome-wide skewed monoallelic
gene expression in diploid cells17, but also variability and gra-
dation of gene expression for different genomic phenomena/
processes, such as imprinting18 and X-inactivation19. These
phenomena are likely the outcomes of the discrete and stochastic
nature of RNA transcription with each gene bearing his own
specific regulation20,21. In diploid cells, it has been already shown
that the large majority of genes respond to a 2-state (ON-OFF)
burst-like model of transcription22 and core promoter elements
and enhancers regulate transcriptional burst size and frequency,
respectively23. Moreover the transcriptional kinetics of the two
alleles of a gene are uncoupled and the alleles are transcribed in
two substantially stochastic24 and independent processes23. It is
still unclear how, in CNA, the presence of additional alleles
impacts the transcriptional activity and causes gene dosage
imbalance. Here we present the comparative analysis of scRNA-
seq from trisomic and matched isogenic diploid fibroblasts. We
show that burst-like transcription shapes gene dosage imbalance
in trisomies. In agreement with the 2-state burst-like model, we
provide evidence that, in trisomic cells, the additional allele is
independently transcribed, leading to an increased monoallelic
expression with respect to the diploid cells, and a significant
fraction of trisomic cells simultaneously activating gene expres-
sion as compared to diploid controls.
Results
Identification of trisomic cells in mosaic cell population. We
used six different cell lines of skin fibroblasts from six individuals:
two samples are from a pair of monozygotic twins discordant for
T2125; four were from individuals mosaics for T21: CM05287,
T13: GM00503, T18: AG13074, T8: GM02596 (Supplementary
Fig. 1 and Supplementary Table 1).
To reduce the allele dropout effect, following the strategy
introduced in26, we performed a split cell experiment where we
manually split the content of a single cell and independently
performed cDNA synthesis in separate tubes. After sequencing
we focused on the common sites detected in the split cells.
Common sites discordant for ASE are a bias introduced by the
allele dropout effect. We observed that discordant monoallelic
sites driven by allelic dropout almost vanished (<1.5%) at
RPSM (Reads Per Site per Million)= 20, similarly to what
previously observed26 (Supplementary Fig. 2).
In order to classify trisomic and diploid cells in a mosaic
trisomy cell population we developed an iterative clustering
method based on k-means (k= 2) using two metrics: the average
cellular gene expression and ASE at heterozygous sites, both
measured from the genes located on the supernumerary
chromosome (details in Methods). Briefly, after quality control
(doublets removal19 - Supplementary Fig. 3) informative hetero-
zygous sites were obtained by whole genome sequencing (WGS)
and ASE was calculated considering the most covered hetero-
zygous site per gene. Each site of the triplicated chromosome has
the allele combination ABB or BAA with two identical alleles
(double allele) and one unique allele. At each round of the
iteration, the double allele is predicted for each heterozygous site
from the average ASE of each predicted single trisomic cell and
the status (diploid or trisomic) of a cell is (re)classified by the k
(=2)-means algorithm. Convergence is reached when the status
of all cells is stable (Supplementary Fig. 4). We examined the
accuracy of this method with a test-set of 316 diploid and
trisomic single cells derived from a pair of monozygotic twins
discordant for T21. We assigned the correct cellular status with
an accuracy of ~95% (5-fold cross validation). It is not currently
possible to independently validate the individual calls of the cells
that have already been sequenced. However, as a further support
of the reliability of the algorithm, the estimated proportion of
cells in the different mosaic cell lines (mosaic T21, T8, T13, T18)
is concordant with the degree of mosaicism derived by
fluorescence in situ hybridization (FISH) (Supplementary Fig. 4).
These results show that the single-cell ASE analysis in combina-
tion with the average cellular expression for triplicated genes can
be used to computationally classify trisomic and diploid cells in
samples from mosaic individuals.
Monoallelic gene expression in trisomic single cell. Previous
studies on allelic expression in diploid cell population have
reported pervasive random skewed monoallelic gene expression
at the single-cell level17,27,28, i.e., cells expressed predominantly
one allele (A or B) at a given time. We observed the same phe-
nomenon in our normal and trisomic cell populations with
around 20–22% of genes presenting a monoallelic expression
(ASE ≤ 0.1; ASE ≥ 0.9, average among all sites within a gene), in
line with what previously reported26. In the diploid fraction of the
genome, in twins’ fibroblasts discordant for T21, 60.1% of the
heterozygous sites showed monoallelic coverage (ASE ≤ 0.1;
ASE ≥ 0.9) in the diploid cells and 70.3% in T21 cells (Fig. 1).
Similar results were obtained for the diploid fraction of the
genome for mosaic T21 cells and the other mosaic trisomies T8,
T18, and T13 cells (Fig. 2). In the monozygotic twins discordant
for T21, the fraction of monoallelic ASE observations from
chromosome 21 sites in diploid cells was 46.5% and 59.4% in
T21 cells (Fig. 1). In agreement with random selection of the
transcribed allele, the fraction of trisomic informative sites
exclusively expressing the unique allele (0 ≤ASE ≤ 0.1) was close
to 1/3 of the total monoallelic observations. Accordingly, in all
trisomy samples, the double alleles on the supernumerary chro-
mosome were detected almost 2 times more frequently than the
unique alleles (Fig. 2). Moreover, the mean of the distribution of
biallelic observations (0.1 < ASE < 0.9) in trisomic single cells was
not equal to 0.5 as in diploid single cells, but shifted towards 0.66
(Figs. 1 and 2). Importantly, these observations are not dependent
on the chosen RPSM threshold (Supplementary Fig. 5). These
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observations support a stochastic model of allelic selection by the
transcriptional machinery where the probability of an allele to be
expressed is linearly dependent on its respective copy number.
Monoallelic expression correlates with expression level. To
further investigate at the single-cell level the gene dosage effect in
trisomic fibroblasts, we classified the triplicated genes based on
their monoallelic expression prevalence (MEP). MEP represents
the fraction of cells per gene with ASE ≤ 0.1 or ASE ≥ 0.9 at the
heterozygous site with the highest number of cellular ASE
observations (Supplementary Fig. 6). We classified the triplicated
genes in three groups: (i) Monoallelic genes: MEP > 80% in
diploid and trisomic cells; (ii) Intermediate genes with MEP
between 20% and 80%; and (iii) Biallelic genes with MEP < 20%
(Fig. 3a). Out of a total of 390 genes, 32% were classified as
monoallelic, 66% as intermediate and only 2% as biallelic (Fig. 3a,
Supplementary Fig. 7). Overall this classification was concordant
for diploid and trisomic cells and consistent with previous single-
cell RNA-seq study26.
We observed a significant negative correlation (spearman
ρ=−0.43, p= 5e-3) between ASE and the level of gene
expression of the corresponding triplicated gene (Fig. 3b,
Supplementary Fig. 7). A similar negative correlation (spear-
man ρ=−0.43, p < 2.2e-16) was also observed for diploid genes
in both the diploid and the trisomic cells (Fig. 3b). According to
the transcriptional bursting model of gene expression, highly
expressed genes have short interburst periods and higher burst
size (number of transcripts produced per burst) than low
expressed genes29. Consequently it is frequent to observe in
single cells random simultaneous (i.e., biallelic) transcription
from the two alleles of highly expressed genes at a given









































Normal cells RPSM = 20
a
b
Informative sites in Chr21
Informative sites GW without Chr21
Fig. 1 Histogram of SC ASE observations in Monozygotic Twins Discordant for DS. a Histogram of ASE observations in chr21 in single cells. Similarly to
genome-wide observations, monoallelic ASE in chr21 is prevalent (46.5% diploid – 59.39% trisomic. Notably, for trisomic SC, monoallelic ASEs on chr21 of
the double allele (0.9-1) are twice as many of monoallelic ASEs of the single allele (0–0.1). Moreover biallelic observations in trisomic single cells are not
centered at 0.5 as in diploid single cells, but at 0.66 (2/3). a Histogram of genome-wide ASE observations in SC excluding chr21 (Blue= diploid Twin,
Red= trisomic Twin). High prevalence of monoallelic ASE observations was observed for both groups (60.14% diploid – 70.3% trisomic). Source data are
provided in the public repository
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transcriptional bursting frequency and therefore the event of a
biallelic simultaneous transcription is rare27.
Fraction of expressing cells causes gene dosage imbalance. In
bulk studies, triplicated genes show overall the expected 1.5 gene
expression fold change (trisomic vs diploid, FC). This observation
has been attributed to the increased amount of transcripts pro-
duced by the triplicated genes. Our study allows a more detailed
interpretation of gene dosage imbalance in aneuploidies. As an
example, considering the previous bulk study on fibroblasts from
the discordant twins for T2130, FC of SLC5A3 between normal
and trisomic state is different between the bulk sample (FC =
2.34) and across the single cells (mean(FC)= 0.97) conversely,
ATP5O has a FC of 1.55 in bulk and 1.47 in single cells (Fig. 4a).
In general, we observed that dosage sensitive genes in the bulk
have a significantly lower FC expression in single cells. FC for 94
chr21 dosage sensitive genes in the bulk sample is superior to 1.2
(T21/N) whereas many genes have a reduced or no gene dosage
effect at the single-cell level (Fig. 4b). The explanation can be
provided considering the stochastic nature of gene expression.
From the master equation of a 2-state promoter, the solution for
genes transcribed in non-overlapping bursts (i.e. rate of gene
inactivation » decay rate) takes the form of a negative binomial31.
Considering the observed expression ratio k/2 (= 3/2 in
triplicated genes versus diploid), we derived the hyperbolic








where s is the distribution of expression levels of g in a bulk of
cells, R is the fraction of cells expressing g and S is the average
(zero truncated) expression of g. Equation (1) reveals the inverse
proportionality between the mean FC in gene expression sks2 and
the K-somic/Diploid ratio of the number of expressing cells RkR2.
The mathematical model shows that genes in three copies with
low expression level in single cells tend to be expressed in more
trisomic cells than diploid cells. This theoretical result, derived
from the 2-state burst-like model of transcription applied to 3
alleles, supports the general hypothesis that a component of bulk
gene dosage imbalance of copy altered genes is generated by the
increased number of cells expressing these genes at a given
time point.
Along this hypothesis, we estimated the fraction of trisomic
cells expressing each triplicated gene R3, and compared to the
fraction of cells of the corresponding diploid sample R2. We
consider a gene as expressed if: (i) the total number of cells
expressing the site within the gene is ≥10, (ii) each cellular ASE
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Fig. 2 Histogram of SC ASE observations in individuals mosaic for different trisomies. Each row represents one mosaic individual. Left Panel: Histogram of
genome-wide ASE observations in SC excluding supernumerary chromosomes. High prevalence of monoallelic ASE observations was observed in all
groups. Right panel: Histogram of ASE observations in SC in the supernumerary chromosomes. In all supernumerary chromosomes monoallelic ASE
observations represent again the higher fraction of ASE observations, similarly to Genome Wide observations. In the trisomic group, monoallelic
observations on supernumerary chromosomes for double allele (0.9–1) are proportionally higher than monoallelic observations of the single allele (0-0.1).
Moreover the distribution of the biallelic observations in trisomic single cells is not centered as in diploid single cells, but shifted towards the double allele.
(Blue= diploid, Red= trisomic). MT = Mosaic Trisomy. Source data are provided in the public repository
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observation has an RPSM score ≥ 20 (Reads Per Site Per
Million17). The genes were classified according to their prevalence
of monoallelic expression (monoallelic, intermediate, biallelic) as
previously defined. Biallelic or intermediate genes did not show
statistically significant differences in the ratio of the fractions of
expressing cells R3R2. In contrast, Twins and mosaic T21, T18, T8,
T13 showed a statistically significant higher fraction of expressing
trisomic than diploid cells of monoallelic genes on the
supernumerary chromosomes with respective p-values 6 × 10−4,
7 × 10−6, 1 × 10−8, 3 × 10−25, 3 × 10−5 (paired Wilcoxon signed-
rank test, two-sided, Fig. 5).
We validated these results with an additional and independent
experiment using the chromium single-cell controller (10X
Genomics)32, a droplet-based system for scRNAseq. We pro-
cessed 3801 diploid single cells and 4939 T21 single cells derived
from the monozygotic twins fibroblasts discordant for T21. After
random selection of an equal number of trisomic and diploid cells
(3800) and normalization with respect to the total number of
UMIs per cell, for each chr21 gene we calculated the expression
distribution in normal and trisomic cell, respectively (Fig. 6a, b).
We compared the gene-matched distributions and, in agreement
with Eq. (1), we noticed that low expressed genes do not
statistically differ in term of expression levels between trisomic
and normal cells (Mann-Whitney test). Conversely average and
highly expressed genes present with a significantly different
distribution (Fig. 6c). Additionally we confirmed that, for chr21
genes only, FC expression of genes and respective FC of number
of expressing cells fit the hyperbolic model of Equation (4) (p=
1 × 10−7, Spearman correlation, Fig. 7 and Supplementary Fig. 8).
As expected, for all genes in the autosomal chromosomes but the
trisomic ones, the fraction of expressing cells was equivalent in
both trisomic and diploid cells (Supplementary Fig. 8). To
combine the two dimensions together, we calculated single-cell
expression distribution and the fraction of expressing cells for
each expressed chr21 gene in the trisomic and normal cells of the
discordant twins. Again in agreement with Eq. (1) and the results
reported in Fig. 6, we observed that the distribution of low
transcribed genes was not significantly different in trisomic versus
normal as it was for average and high transcribed genes (Fig. 8).
More specifically, we observed that gene dosage insensitive genes
(0.8 < FC < 1.2), tend to exhibit a higher median fraction of
trisomic vs diploid expressing cell ratio (1.3, p= 5 × 10−10,
Mann–Whitney U test) (Fig. 8). This result indicates that the
fraction of expressing cells is the main component of gene dosage
imbalance for such genes. Notably, low expressed genes in chr21
(183 genes) showed a higher R3R2 than intermediate (22 genes) and
highly expressed genes (9 genes) (Fig. 8). We conclude that for
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Fig. 3 Prevalence of monoallelic expression in supernumerary chromosomes. a Classification of genes in three groups (Monoallelic, Intermediate, and
Biallelic). Genes for which >80% of cells show monoallelic expression were classified as monoallelic (ASE≤ 0.1 or ASE≥ 0.9); genes with 20–80% of cells
with 0.1≤ASE≤ 0.9 were classified as intermediate; genes with <20% of cells with 0.1≤ASE≤0.9 were classified as biallelic. b Monoallelic prevalence is
negatively correlated with level of gene expression both genome-wide (diploid fraction of the genome—upper panel) and within the trisomic fraction of the
genome (chr21—lower panel). Source data are provided as Source Data file
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by the higher fraction of T21 expressing cells (p= 1 × 10−6,
Mann–Whitney U test, Fig. 8). Conversely, for intermediate and
highly expressed genes, the main component of gene dosage effect
is the higher expression of triplicated genes in each single cell
(p= 2 × 10−5 and p= 0.03 Mann–Whitney U test, respectively,
Fig. 8).
Discussion
Gene dosage imbalance caused by CNA is generally interpreted as
the altered production of transcripts per cell. The typical example
is represented by trisomies where several studies on mouse and
human samples reported the classical 1.5 average gene expression
fold change7,30,33–39. The investigation of this phenomenon at
single-cell level opened a more complex scenario. As a first
observation, we detected reduced or no dosage effect at all for
some genes on a single-cell level, compared to the expected fold
change from our previous bulk study in T21. Moreover, ASE
exploration of the supernumerary chromosome genes in our iso-
genic models of trisomies showed clear random monoallelic pat-
terns of expression as already observed in diploid cells17,26,28. We
confirmed that these patterns follow a random allelic selection
model by observing that the number of observations expressing
the duplicated allele was indeed twice the number of those
expressing the single allele. As previously shown17,26, we observed
that the monoallelic prevalence of expression (the fraction of cells
in which the gene appears as expressed by one allele only) is
negatively correlated with the level of expression of the respective
genes. Finally, we observed that the increased fraction of trisomic
cells vs. diploid presenting with active expression of super-
numerary chromosome genes is contributing to the average
dosage imbalance of all the trisomies analyzed in this study. This
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Fig. 4 Fold change expression comparison in bulk and single-cell study.
a Left: Distribution of expression levels of ATP5O in diploid (blue) and T21
(red) single cells. The gene presents with the typical trisomy gene dosage
effect meanT21/mean= 1.5 as observed in the bulk (FCbulk= 1.5). Right:
Distribution of expression levels of SLC5A3 in diploid and T21 single cells. The
two distributions are similar and the gene does not present the typical gene
dosage effect as observed in the bulk (meanT21/meanD= 1, FCbulk= 2).
b Left: Comparison of expression fold change for dosage sensitive genes in
the bulk (FCbulk > 1.2, 94 genes) and SC of twins discordant for T21. Right:
Comparison of expression fold change in bulk and SC for a subset of bulk-
dosage sensitive genes presenting with a non-dosage sensitive effect in SCs
(insensitive in SC) (0.8 < SC FC < 1.2, 17 genes). Boxplot: horizontal lines
indicate medians; upper and lower boxes indicate first (25th percentile) and
third quartiles (75th percentile); whiskers indicate first quartile—1.5 IQR
(interquantile range= first–third quartile) and third quartile+ 1.5 IQR. Source

















































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 5 Higher fraction of expressed cells for supernumerary chromosome
genes. In all trisomies an increased fraction of single trisomic cells
expressing supernumerary monoallelic genes is detectable. P-values in the
figure indicate the respective statistical significance of the comparisons
between diploid and trisomic cells. Blue—fraction of diploid single cells. Red
—fraction of trisomic single cells. Boxplot: horizontal lines indicate medians;
upper and lower boxes indicate first (25th percentile) and third quartiles
(75th percentile); whiskers indicate first quartile—1.5 IQR (interquantile
range= first–third quartile) and third quartile+ 1.5 IQR. MT = Mosaic
Trisomy. Source data are provided as Source Data file
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The theoretical application of the 2-state burst-like transcrip-
tional model to trisomies provides an explanation of these
observations (Eq. (1)). For average and highly expressed genes
(i.e., housekeeping and maintenance of cell function), transcrip-
tional bursting events are frequent in both diploid and trisomic
single cells. For these genes, the model predicts an increment of
RNA molecules at single-cell level and in all single cells.
Accordingly, we observed no significant difference in the fraction
of expressing cells. Conversely, for low expressed genes with a low
bursting frequency and burst size, the model predicts that the
presence of additional alleles increases the number of random
transcriptional events in more single cells. Being rare events
hardly happening simultaneously in the same cells, the tran-
scriptional bursts of low transcribed duplicated genes do not lead
to a detectable increased amount of RNA quantity in the single
cell but instead to an increased monoallelic expression prevalence
in a higher fraction of expressing cells with respect to diploid
controls. We have shown that this model fits quite closely the
experimental data describing a whole spectrum between the two
above-mentioned extremes (Fig. 7). Duplicated genes with aver-
age expression will present gene dosage imbalance with a com-
bination of RNA accumulation and fraction of expressing cells
accordingly to the inverse relationship described by Eq. (1).
This observation may have a significant impact on the
understanding the molecular pathophysiology of aneuploidies. As
an example, transcription factors (TF) have in general a lower
expression level than non transcription factor genes40. TF dosage
imbalance leading to an increased number of a activated cells
could be crucial in the following (the list is not exhaustive): (1)
different fractions of cells producing increased level of subunits of
multimeric proteins may result in abnormal stoichiometry41,42;
(2) abnormal number of cells with cell surface receptors and
ligands that may results in a disturbed developmental fate43,44; (3)
abnormal number of transporter molecules in the tissue resulting
in metabolic disturbances45; (4) excess of cell adhesion molecules
that may increase cellular adhesiveness and differential fate of a
tissue46; (5) alteration in the production, concentration and dif-
fusion of morphogens in the tissue and consequent abnormal
cellular proliferation and development of aberrant cellular and
tissue structures47. Furthermore, the unbalanced expression of
low expressed copy altered regulatory long non-coding RNAs and
microRNAs in a fraction of cells may also contribute to the dis-
turbance of the regulatory repertoire of other cells, particularly
during embryogenesis48. Indeed many of these phenotypes may
manifest during the early embryonic development stages where a
precise and delicate balance among gene pathways dedicated to
coordinate cell-to-cell interactions as well a as specific partition
among cell types must be maintained49. Additionally this effect
can be mediated by the duplication of regulatory regions that
modulate gene expression through specific regulatory variants.
eQTLs in trisomic regions have 4 possible states (AAA, AAB,
ABB, BBB) instead of the canonical (AA, AB, BB) in the diploid
genome. This additional degree of freedom might modulate the
spectrum of gene dosage imbalance in term of RNA accumulation
and fraction of expressing cells and contribute to the considerable
phenotypic variability among affected individuals. More gen-
erally, we propose that the spectrum of gene dosage may con-





















































Fig. 6 Distribution of expression levels of chr21 genes in trisomic and
normal cells. a, b Distribution of expression levels (log(RPKM) on the
y-axis, counts are color coded) of genes in chr21 (on the x-axis, sorted by
increasing average expression) in 4939 trisomic and 3801 diploid cells,
respectively. c Significance of the gene-matched (on the x-axis) statistical
comparison (on the y-axis) of trisomic (a) and diploid (b) distributions. Low
expressed genes (on the left) tend to have a similar distribution in trisomic
and diploid cells (no significant difference) as opposed to the average and
highly expressed genes (on the right). Source data are provided in the
public repository
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including Copy Number Variants (CNVs) and somatic partial
aneuploidies typical of cancer cells50. Based on this considera-
tions, it is straightforward to hypothesize that strong regulatory
variants on low expressed genes may induce gene dosage diversity
in general population. Time-series single-cell RNAseq studies in
normal and aneuploid differentiating embryos are needed to
reveal how the spectrum of gene dosage imbalance determines
individual phenotypic features.
Methods
Ethical statement. The study was approved by the ethics committee of the Uni-
versity Hospitals of Geneva, and written informed consent was obtained from both
parents of the twins.
Samples. We used six different cell lines of skin fibroblasts from six individuals: two
samples are from a pair of monozygotic twins discordant for T2125; four were cell
lines obtained from Coriell and derived from individuals mosaics for T21:
CM05287, T13: GM00503, T18: AG13074, T8: GM02596 (https://www.coriell.org/).
DNA samples from peripheral blood were obtained from the parents of the
monozygotic twins. Cell lines from mosaic individuals T8, mosaic T13, mosaic T18,
were purchased from Corriel, and sample from mosaic T21 was kindly provided by
Prof. Dean Nizetic. We captured in total 928 single-cell fibroblasts (484 diploid and
444 Trisomic) using the Fluidigm C1 technology. In addition we employed an
alternative single-cell RNA-seq protocol based on 10X Genomics technology
(Chromium Single cell 3’ Solution protocol32) to capture 8740 single cells (3801
diploid and 4939 trisomic single cells) (Supplementary Table 1).
Analysis of genome-matched samples. The comparison of transcriptional pro-
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Fig. 7 Higher fraction of expressing cells of trisomic genes in 8740 single fibroblasts. Upper row, left: (y-axis) distribution of fraction of trisomic cells
expressing chr21 genes; (x-axis) distribution of fraction of diploid single cells expressing chr21 genes; right: data for chr1 as control. Lower row, left: T/D
ratio of number of expressing cells and T/D ratio of single-cell expression of genes in chr21 are inversely correlated (Spearman correlation); right: data for
chr1 as control. Cells with >5 reads and genes expressed in >50 cells have been considered. Red line is to guide the eye (see text for details). Source data
are provided in the public repository
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Notably, in this study, we sought to eliminate the inter-individual bias by com-
paring diploid and trisomic single-cell fibroblasts from individuals with mosaicism
for the relevant trisomies (T8, T13, T18, T21) and by using single-cell fibroblasts
from monozygotic twins discordant for DS (T21) (Supplementary Fig. 1 and
Supplementary Table 1).
Cell culture. Cells were cultured in DMEM GlutaMAX™ (Life Technologies)
supplemented with 10% fetal bovine serum (Life Technologies) and 1% penicillin/
streptomycin/fungizone mix (Amimed, BioConcept) at 37 °C in a 5% CO2
atmosphere. The day before the single-cell capture experiment; cells were
trypsinized (Trypsin 0.05%-EDTA, Life Technologies) and replated at a density
of 0.3 × 106 cells/100-mm dish.
Fluorescence in situ Hybridization. Fluorescent in situ Hybridization (FISH)
analysis was performed on cultured-interphase nuclei with 2 set of probes: two
locus specific probes on chromosome 13 (Vysis RB1;13q14 locus) and chromosome
21 (Vysis, D21S342/D21S341/D21S259 contig probes), and two alpha satellite cen-
tromere probes for chromosome 8 (Vysis, D8Z1) and chromosome 18 (Vysis,
D18Z1). The experiments were carried out according to manufacturer’s instruc-
tions (Aneuvysion, VYSIS Inc.). For each sample 150 interphase nuclei were
examined to evaluate the mosaic rate.
Whole-genome sequencing. Genomic DNA was extracted for five individuals
using a QIAamp DNA Blood Mini Kit (Qiagen) and fragmented by Covaris to peak
sizes of 300–400 bp. Libraries were prepared with TruSeq DNA kit (Illumina) using
1 µg of gDNA and sequenced on an Illumina HiSeq 2000 machine with 2 ×
100-bp17. All experiments were performed using the manufacturer’s protocols. All
samples provided with an whole genome average coverage around 25×. For each
individual, raw whole genome DNA sequences were analyzed using an in-house
pipeline. Briefly, we used the BurrowsWheeler Aligner (BWA mem v.0.7.10) to
align the sequencing reads (fastq) to the human reference genome (GRCh37/hg19).
We used SAMtools v.1.451 to remove paired-end duplicates and pile up the
remaining reads. BCFtools v.1.4 was used to call the SNVs and Annovar
(2016Feb01)52 for the annotation. SNVs with quality score <100 where excluded
from the analysis. All putatively biased sites with low mappability (i.e. in repeated
or bad quality regions) were removed from the analysis as suggested by Panousis
et al.53. Similarly to18,19, we only used uniquely mapped reads for SNV calling.
Single-cell capture (C1 Fluidigm). Single-cell capture was performed by C1
single-cell auto prep system (Fluidigm) following the manufacturer’s instructions17.
The microfluidics circuit used was the C1™ Single-Cell mRNA-seq IFC, 17–25 µm.
All 96 chambers were inspected under an inverted phase contrast microscope; only
chambers containing a non-damaged single cell were considered for downstream
analysis. For the cell lysis and cDNA synthesis, we used the SMARTer Ultra Low
RNA kit for Illumina Sequencing (version 2, Clontech) and a C1 Auto Prep System
instrument (Fluidigm) with the original mRNA Seq Prep script provided by the
manufacturer (1772×/1773×, Fluidigm). We assessed cDNA quality on 2100
Bioanalyzer (Agilent) with the high sensitivity DNA chips (Agilent) and quantified
the cDNA using Qubit dsDNA BR assay kit (Invitrogen). Sequencing libraries were
prepared with 0.3 ng of pre-amplified cDNA using Nextera XT DNA kit (Illumina)
according to manufacturer’s instructions. Libraries were sequenced on an Illumina
HiSeq2000 machine as 100 bp reads single-end.
GemCode single-cell libraries preparation and sequencing. We captured in
total 3801 diploid and 4939 trisomic single-cell fibroblasts from the monozygotic
twin pair using the Chromium System powered by GemCode Technology (10x
Genomics). Single-cell RNA-seq libraries were generated using the Chromium
Single Cell 3' Reagent Kit version 2 (10x Genomics) according to the manu-
facturer’s instructions. Briefly, the concentration of trypsin dissociated fibroblasts
was set to 1500 cells/µl of culture medium (Dulbecco’s Modified Eagle Medium
(DMEM), 10% FBS) and 5000 individualized cells were flown per channel fol-
lowing the recommendation of the manufacturer. All libraries were quantified by
Qubit (Invitrogen) and by quantitative real-time PCR using the PCR-based KAPA
Library Quantification Kits for Illumina platforms (Kapabiosystems). Size profiles
of the pre-amplified cDNA and sequencing libraries were assessed using a 2100
BioAnalyzer (Agilent) with a High Sensitivity DNA chip kit (Agilent). Barcoded
libraries were sequenced with an HiSeq 4000 (Illumina) as paired-end 100 bp reads
as recommended by 10x Genomics. The proprietary software CellRanger (10x
Genomics) with default parameters was used in order to demultiplex the samples
and quantify the abundance of mRNA molecules (UMI - Unique Molecular
Identifier). Processed data were analyzed using custom R scripts.
C1 Single-cell RNA-sequencing. For single cells capture with the Fluidigm C1
microfluidics system, SMARTer Ultra Low RNA kit for Illumina sequencing
(version 2, Clontech) was used for cell lysis and cDNA synthesis. 0.3 ng of pre-
amplified cDNA, was used for the library preparation with the Nextera XT DNA
kit (Illumina) as described17. Libraries were sequenced on an Illumina
HiSeq2000 sequencer as 100 bp single-ended reads. RNA sequences were mapped
with GEM54. Uniquely mapping reads were extracted by filtering for mapping
quality ≥ (MQ ≥ 150). For FPKM expression quantification an in-house algorithm
was used with GENCODE v19 as reference. Cells with less than 1o million reads
and/or cells with <10% of expressed genes (total number of 56680 genes) were
excluded from the analyses. For each individual, ASE of each heterozygous SNP
identified by WGS has been calculated using in-house developed Python scripts.
Data have been analyzed using custom R scripts.
Allele-specific expression. Cellular Allelic Specific Expression (ASE) of each
heterozygous site was calculated in the diploid and trisomic fraction of the genome
of each single cell per individual using two different formulas.
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Fig. 8 Components of gene dosage imbalance in trisomy 21 using
8740 single fibroblasts. Left: Gene dosage imbalance components in low
(<3 FPKM), medium (3 FPKM< and <15 FPKM) and high (>15 FPKM)
expressed genes. For low expressed genes, dosage imbalance is mainly
driven by the increased fraction of trisomic cells expressing these genes
compared to diploid. For medium and highly expressed genes, the dosage
imbalance is mainly driven by the trisomic/diploid FC expression per cell
while no significant difference in the fraction of cells can be detected. Right:
statistically significant differences of trisomic/diploid ratio of fraction of
expressing cells in non-dosage sensitive genes in single cells (0.8 < FC <
1.2). Boxplot: horizontal lines indicate medians; upper and lower boxes
indicate first (25th percentile) and third quartiles (75th percentile);
whiskers indicate first quartile—1.5 IQR (interquantile range= first–third
quartile) and third quartile+ 1.5 IQR. Source data are provided in the public
repository
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12273-8 ARTICLE








nreadsðSA; iÞ þ nreadsðDA; iÞ
where nreads is an operator giving the number of reads covering the site i, mapped
according to the REFerence or the ALTernative allele (euploid) or to the Double or
Single Allele (trisomic).
In both cases, ASE values range from 0 to 1 (Supplementary Fig. 5). We
consider 0 ≤ASE ≤ 0.1 as the signature of monoallelic expression of the Alternative
allele (euploid) or Single allele (trisomic). Conversely 0.9 ≤ASE ≤ 1 indicates
monoallelic expression of the Reference allele in the case of diploid cells or of the
Double allele in the case of (trisomic cells). ASE from 0.1 to 0.9 is an indicator of
biallelic expression.
Single cells identification in mosaic populations. We developed a computa-
tional procedure to distinguish diploid from trisomic single cells in mosaic
populations. Using an iterated k-means (k= 2) approach, we combined ASE
profiling and expression data of every expressed site in the supernumerary
chromosomes to classify each single cell as diploid or trisomic. At the beginning
the algorithm applies a k(=2)-means clustering to obtain the first partition of
normal and trisomic cells using as features average minmax normalized gene
expression x cell and average ASE x cell. The rationale is that average gene
expression of genes in the supernumerary chromosome is on average higher than
the corresponding gene in the diploid cell with the same genetic background
(i.e., no difference in regulatory regions). Moreover, as previously shown,
average ASE calculated with respect to the double allele in trisomic cells (see
Methods) is higher than the corresponding ASE in diploid cells. However, since
we do not know a priori the allele in two copies (double) the accuracy of the first
partition is expected to be quite poor. Therefore the next step is to estimate for
each heterozygous site the double allele using ASE imbalance of single cells.
More specifically, the average ASE x site is calculated across all single cells tagged
as trisomic in the previous iteration and the double allele assigned to each site as
the max expressed allele. Once this estimation is done, the improved ASE pre-
diction is used in a new k(=2)-means iteration to improve the partition of
trisomic and diploid cells (the second feature is again the average gene
expression). K-means cell clustering and double allele estimation are repeated
until convergence is reached (i.e. trisomic and diploid cell clusters are stable, no
reassignment) (Supplementary Fig. 4).
Fluidigm C1 multiple cells (doublets) detection. In our Fluidigm C1 based
protocol, we set two checkpoints where double cells (doublets) are identified and
eliminated. First, during the capturing procedure, doublets are identified by visual
inspection under the microscope, and eliminated from further analysis. Second,
after RNA sequencing and ASE analysis, potential double cells of female indivi-
duals are eliminated based on the study of X chromosome haplotype expression.
For each cell, the expressed haplotype is estimated by calculating the allelic ratio of
each heterozygous site in the X chromosome as identified by whole genome
sequencing. Sites in the pseudoautosomal regions (PAR1 chrX:60001–2699520,
PAR2 chrX:154931044–155260560) and known escapee genes are a priori exclu-
ded. The estimated haplotype of each cell was compared to all the others
through correlation based hierarchical clustering. Cells expressing concordant
and discordant haplotypes results in a correlation near 1 and −1 respectively.
Doublets simultaneously expressing both discordant haplotypes cluster around the
absolute correlation of 0.5 and are excluded from further analysis (Supplementary
Fig. 3).
Allele dropout control. To reduce the potential bias induced by allele dropout, we
have utilized the RPSM metric (Reads per site per million mapped reads)17.
Through split cell RNA experiments based on ERCC RNA spike-in mix
(Ambion)17, we identified the threshold RPSM= 20 to drastically reduce false
positive monoallelic ASE calls (Supplementary Fig. 2). Additionally we only con-
sider heterozygous SNV sites covered by at least 16 reads to further minimize
possible allele dropout effects55.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Fluidigm C1 Sequencing data for Discordant T21 Twins and mosaic T18 and T8 are
available in the Gene Expression Omnibus (GEO) data repository (accession no.
GSE123028). Sequencing data for Discordant T21 (10X Genomics), Mosaic T21 and T13
(Fluidigm C1) are available in the Gene Expression Omnibus (GEO) data repository
(accession no. GSE135500). All other relevant data are available upon request.
Code availability
Python and R code used in this study is available upon request.
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